PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Change in Accured Expenses (2021 - 2026)

PepGen (PEPG) posted Change in Accured Expenses of -$3.5 million for Q1 2026, down 1482.75% sequentially from $255000.0 in Q4 2025, and down 230.06% YoY from $2.7 million in Q1 2025.

Analysis

PepGen (PEPG) Change in Accured Expenses (2021 - 2026) Analysis & Trends

PepGen has reported Change in Accured Expenses for 6 years, with the latest figure at -$3.5 million in Q1 2026.

  • Quarterly Change in Accured Expenses fell 230.06% year-over-year to -$3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.5 million (down 221.66% YoY) and the FY2025 annual result came in at -$3.3 million, down 96.51% from the prior year.
  • Change in Accured Expenses slipped to -$3.5 million in Q1 2026 per PEPG's latest filing, from $255000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $6.5 million in Q1 2022 and troughed at -$6.8 million in Q1 2024.
  • A 5-year average of -$88470.6 and a median of $166000.0 in 2023 frame the typical range for Change in Accured Expenses.
  • The widest YoY moves for Change in Accured Expenses: up 829.66% in 2024, down 4175.3% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $2.1 million in 2022, then slumped by 127.42% to -$563000.0 in 2023, then soared by 825.93% to $4.1 million in 2024, then tumbled by 93.76% to $255000.0 in 2025, then sank by 1482.75% to -$3.5 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$3.5 million, $255000.0, and -$4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 PepGen 217.99 Mn 217.99 Mn - -465,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -465,000.00
Mar 31, 2026 -3.53 Mn
Dec 31, 2025 255,000.00
Sep 30, 2025 -4.02 Mn
Jun 30, 2025 -2.22 Mn
Mar 31, 2025 2.71 Mn
Dec 31, 2024 4.09 Mn
Sep 30, 2024 -3.49 Mn
Jun 30, 2024 4.50 Mn
Mar 31, 2024 -6.77 Mn
Dec 31, 2023 -563,000.00
Sep 30, 2023 2.44 Mn
Jun 30, 2023 -617,000.00
Mar 31, 2023 166,000.00
Dec 31, 2022 2.05 Mn
Sep 30, 2022 -4.45 Mn
Jun 30, 2022 1.47 Mn
Mar 31, 2022 6.45 Mn
Dec 31, 2021 -364,000.00
Sep 30, 2021 3.96 Mn